Genentech Inc. has recalled 2,627 bottles of Evrysdi (risdiplam) for oral solution (60 mg/80mL). The recall was initiated because some bottles were packaged with incorrect press-in-bottle-adapters (PIBA) that have a female fitting instead of the required male fitting. This defect prevents the adapter from connecting properly with the co-packed syringes, making it difficult or impossible to administer the medication correctly. Consumers should contact their healthcare provider or pharmacist for guidance on obtaining a functional replacement or adapter.
The incorrect adapter fit prevents the medication from being drawn into the co-packed syringe. This could lead to a delay in treatment or incorrect dosing for patients relying on this prescription medication.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.